Best Biohacking Tools and Supplements From Kevin Rose's Random Show

This content is for informational purposes only and is not a substitute for professional advice.

Kevin Rose runs the most gadget-heavy self-experimentation program in podcasting. Across The Random Show with Tim Ferriss and his solo interviews on The Kevin Rose Show, the same pattern repeats every few months: a new device arrives, a compound gets tested, labs come back, and the two of them triangulate what actually moved. This post reads the biohacking-relevant episodes across both feeds and compresses them into something a serious self-experimenter can act on, organized around the themes Rose and his guests keep returning to.

Three patterns show up in almost every useful episode. The first is that Rose treats health gadgets and supplements as tools inside a decision loop, not identities: buy the device, run it for a defined window, keep it if the data says keep it, otherwise sell it on Craigslist and move on. The second is that he stays close to clinicians with actual practices — Peter Attia, Matt Walker, Andrew Huberman, Casey Means — so the stack evolves against labs and published evidence rather than internet hype. The third is a visible tilt toward longevity bets with plausible mechanism (rapamycin, urolithin A, creatine, ketones) and skepticism of anything with only mouse data and a Twitter thread behind it.

The operating principles that surface repeatedly across the episodes in this rollup:

• Buy gadgets that change behavior, not dashboards. A tool that produces a number you ignore is worse than no tool. Sleep regularity, training volume, alcohol count, and glucose variance are the metrics that actually move outcomes.
• Run every new compound as a bounded experiment. Pick one outcome, pick a window, invoke the stop rule if it produces a consistent negative effect, and drop it without drama when it does not earn its slot.
• Anchor the stack to bloodwork. Vitamin D, ApoB, Omega-3 Index, homocysteine, and fasting insulin are the inputs that tell you which supplements are doing something and which are theater.
• Longevity compounds come in tiers. Creatine and omega-3 are nearly free wins. Rapamycin, urolithin A, ketones, and methylene blue are real experiments with real trade-offs and clinician supervision.
• Sleep is the fastest lever. Fixing caffeine timing, room temperature, and alcohol beats almost every sleep supplement. Trackers only help if the number you read in the morning changes something during the day.
• Treat GLP-1s and longevity drugs as medical tools, not shortcuts. Microdosing, cycling, and side-effect monitoring are the entire point of bringing them through a clinician.
• Keep the consumer stack small and third-party tested. Rose's published list is a short run of quality-controlled products supporting a bigger longevity bet, not a pill pyramid.
• The most valuable experiments are the ones that fail cleanly. Ozempic, aggressive keto, and SAINT-style TMS all produced course-corrections that would have been impossible without structured measurement.

Gadgets and the measurement layer

The Random Show is where gadgets get pressure-tested. An HRV chest strap, a ketone meter, a $900 vagus nerve clip, a $30k photobiomodulation laser — each one gets tried, logged, and either kept or shelved. The durable takeaway across years of episodes is that the gadget only earns its slot when its output changes what you do the next day.

The Random Show — Couch Edition (Mar 18, 2026) — Episode #858

Transcript

The most recent supplement-heavy Random Show is a useful snapshot of where the stack sits in 2026. Rose and Ferriss walk through methylene blue on Amazon, urolithin A for mitochondrial upkeep, photobiomodulation lasers for cognitive protection, and blood-flow-restriction bands for aging joints. The through-line is that almost every new tool is a hormetic dose with a U-shaped response curve.

1. Treat methylene blue as a hormetic compound, not a megadose candidate. Small doses support mitochondrial function; large doses reverse it, and the Amazon supply chain is not built to protect against that.
2. If you run methylene blue at all, do it under clinician guidance, avoid serotonergic medications because of interaction risk, and invoke a stop rule at the first sign of GI distress or headaches.
3. Urolithin A earns a stack slot because oral bioavailability is good and the dietary route (pomegranates, walnuts) produces wildly variable conversion. Dose daily; retest mitochondrial markers when you can.
4. Photobiomodulation is a "track it, then keep it" candidate. Run it once a week, log cognitive output before and after, and drop it if the signal does not clear baseline variance.
5. Blood-flow-restriction bands let older-joint lifters get hypertrophy stimulus at lower loads. Cap sessions; the stimulus is real and so is the cardiovascular stress.
6. Norwegian 4×4 intervals (four rounds of four minutes near VO₂max) show up as Rose's preferred protocol for pushing lactate and, by extension, brain fuel. Two sessions a week is the evidence-supported dose.

The Random Show — Ketones for Cognition and Tim's Best Labs (Aug 13, 2025) — Episode #822

Transcript

This is the episode where Ferriss reports his best lipids in a decade on a ketogenic plus 16:8 plan, Rose celebrates 100 days sober, and both of them debate exogenous ketones, microdosed GLP-1s, and DORA sleep medications. The underlying thesis is that cognitive protection is now an engineering problem with real tools, not a wait-and-see.

1. When a lab panel moves unexpectedly on a new diet, look at food selection before concluding the framework failed. Keto on butter and cream is not keto on olive oil and fatty fish, and the lipids reflect that.
2. Exogenous ketones split into two tiers. Ester-based products (Delta-G class) produce the strongest brain effect; salt-based ketones are cheaper but weaker. Anything containing 1,3-butanediol should be used sparingly because of liver risk.
3. Microdosed GLP-1 agonists like tirzepatide are a clinician-guided glucose-control tool, not a weight-loss hack. Pair them with resistance training and adequate protein to protect lean mass; otherwise the muscle loss is real.
4. DORA-class sleep medications (suvorexant/Belsomra class) are better studied than benzodiazepines for people chasing architecture-preserving sleep, but still need a prescriber, a short trial, and an honest morning-after check.
5. For sauna, calibrate temperature to the protocol Patrick's work supports (roughly 174–180°F for 20+ minutes, several times a week) and track it as training rather than hoping hotter means better.
6. There are no free lunches in biology. Every intervention that moves a number meaningfully is going to move another number. Budget for that when you design the experiment.

The Journal with Kevin Rose — Continuous Glucose Monitoring With Josh Clemente (Sep 3, 2020) — Episode #43

Show Notes

Rose's early episode with the Levels Health founder is the cleanest argument in his catalog for why short-window CGM use belongs in a serious stack audit. The insight is that two people eating identical meals can diverge sharply in glucose response, which reframes "what to eat" as a measurement question before it becomes a macros question.

1. Use a two-to-four-week CGM wear as a learning tool, not a permanent dashboard. The goal is to identify the meals that reliably spike you and the combinations (protein plus fiber plus fat) that flatten the curve.
2. Post-meal movement is the single highest-leverage glucose intervention that does not require a supplement. Ten to twenty minutes of walking after the day's largest meal does most of the work.
3. Use meal ordering (vegetables and protein before starches) as a durable glucose habit once the CGM comes off. This is structural, not a hack.
4. Consistency of meal timing reduces variance in glucose response almost as much as composition. Eating randomly across a twelve-hour window blurs the signal.
5. Late-evening carbohydrates produce worse responses than the same meal at lunch for most people. Move starch earlier when possible.
6. Glucose variability, not average glucose, is the biohacker-relevant signal. A flat 95 mg/dL average with huge swings is a worse metabolic state than a boring 98 with tight variance.

Longevity compounds and what Rose thinks about skipping

Rose has logged more hours with Peter Attia than almost anyone else on this list, which is why the longevity conversations across his catalog are unusually calibrated. Compounds move between "promising" and "not ready" depending on human data, not announcements. The longevity supplements and aging biomarkers post is the companion that tracks where the evidence actually sits.

Kevin Rose Show — Peter Attia on Rapamycin, Fasting, and Longevity (Jan 17, 2019) — Episode #25

Show Notes

This is the episode where Attia first publicly discusses his own rapamycin use and lays out the framework he still applies in 2026. The takeaways are durable because Attia frames every compound as a bet with incomplete information, priced against alternatives.

1. Rapamycin is worth tracking as the most plausible healthy-human longevity compound, but the risk/benefit map is still being drawn. Pulsed dosing, lab monitoring, and a real prescriber are the only way to run this experiment.
2. Fasting-mimicking and longer fasts have different targets. Short daily windows help with adherence and glucose; five-day fasts push autophagy and stem-cell signals that daily fasting does not.
3. Metformin is a useful tool for metabolic dysfunction but is not an upside-only longevity bet. Blunted training adaptation is a real cost in people who are already metabolically healthy.
4. Most "longevity supplements" fail on the same test: mouse data, no human outcome data, and a supply chain with no third-party testing. Spend the money on the things that survive this filter.
5. The foundational moves — resistance training, aerobic base, sleep, metabolic control — outrank every compound in the current catalog. Treat supplements as margin, not as the stack.
6. Build a personal risk map (cardiovascular, metabolic, neurodegenerative, cancer) and stack interventions against your top two risks. Generic longevity stacks ignore the distribution that actually matters.

Kevin Rose Show — Valter Longo on the Longevity Diet and FMD (Dec 31, 2017) — Episode #14

Show Notes

Longo is the episode that rewired Rose's diet. The five-day fasting-mimicking diet (FMD) became a recurring protocol in both his life and Ferriss's, and the conversation remains the clearest framing of why short structured fasts are a different tool than everyday caloric restriction.

1. Run the FMD as a three-to-four-times-per-year protocol rather than a permanent diet. The effect is in the cycling, not in living at the calorie floor.
2. Use the keto-adjusted version Attia refined — higher fat, lower refined carbs — if lipids are already a concern. The original FMD is plant-heavy but carries enough starch to blunt ketosis for some people.
3. Pair the fast with reduced training volume. Heavy lifting during the fast is a muscle-loss invitation that cancels out the point of the protocol.
4. The centenarian dietary pattern sits in the same lane as the Mediterranean diet with more legumes and less meat. Use it as the default between FMD cycles rather than as an aspirational target.
5. Stop the fast if something feels wrong. Lightheadedness, tachycardia, or persistent headaches are stop-rule triggers, not badges.
6. FMD is a clinical tool first and a biohack second. People on insulin, on blood pressure medication, or with a history of eating disorders should run it with a physician, not YouTube.

The Random Show — Sabbatical, Klotho, and Alzheimer's Research (Sep 4, 2024) — Episode #766

Transcript

This is the episode where Rose introduces Dena Dubal's Klotho protein research as a possible Alzheimer's intervention and Ferriss walks through ketamine therapy for depression. The quiet point is that the interesting frontier in 2024–2026 is compounds that act on brain aging, not muscle aging.

1. Klotho is a promising longevity protein with early Alzheimer's data, but it is a research program, not a supplement on Amazon. Track the trials rather than chasing unvalidated Klotho-boosters.
2. APOE4 carriers have a different risk profile and should think about cognitive-protection interventions earlier. Genotype first, then intervene.
3. The Bredesen Protocol is a structured framework for people at APOE-elevated risk: diet quality, exercise, sleep, supplements, and targeted environmental changes run together. It is not a pill.
4. Ketamine therapy, done in a clinical setting with a prescribing physician, has a different risk/benefit profile than recreational use. Treat the setting and the integration work as half of the intervention.
5. For vampire facial and platelet-rich plasma experiments, the downside is a sterility problem, not a theoretical one. Lower-cost providers are not saving you money; they are sending you to urgent care.
6. Keep the supplement list unchanged during any intense therapeutic experiment. You cannot evaluate two interventions at once without losing the signal from both.

Sleep and nervous-system tools

Sleep is the subject Rose has reinterviewed the most across years — Matt Walker twice, Andrew Huberman as the show's signature neuroscience guest — which is why the sleep advice across the catalog is unusually consistent and unusually device-aware.

Kevin Rose Show — Andrew Huberman on Sleep, Supplements, Sunlight, and Stimulation (Feb 14, 2021) — Episode #46

Show Notes

Huberman's first appearance on Rose's show is a compact, gadget-friendly version of the operating system he has since expanded across Huberman Lab. Morning light, NSDR, nostril breathing, and a deliberately short supplement list form the core. The full catalog-level view lives in the Huberman Lab rollup.

1. Use 5–15 minutes of morning sunlight exposure as the most reliable tool for stabilizing the circadian system. It beats any light-therapy gadget when real sunlight is available.
2. Treat melatonin skeptically as a default sleep aid. It is a hormone, doses are often 10–100x higher than needed, and product quality varies wildly across the supplement aisle.
3. Use magnesium-threonate, apigenin, and theanine as a conservative evening stack. Rotate rather than run all three every night; a stack cycle avoids tolerance and makes the next reset more effective.
4. Creatine is the single supplement Huberman will endorse across nearly every stack. 5 grams daily supports cognition, training, and, based on recent data, may help under sleep-deprived conditions.
5. NSDR (non-sleep deep rest) is the best non-drug recovery tool for an afternoon reset. Ten to twenty minutes beats a nap for most schedules.
6. Breathing is the cheapest nervous-system lever. Long exhales downshift; the double-inhale physiological sigh clears stress faster than most interventions; reserve Wim Hof–style hyperventilation for controlled contexts because blackout risk is real.

Kevin Rose Show — Matt Walker, Optimizing Sleep (Sep 3, 2021) — Episode #48

Show Notes

Rose's first Walker interview is the cleanest summary in his catalog of why sleep is foundational rather than optional. The behaviors line up with what Walker says elsewhere but the framing is tool-friendly: these are things you can check off tonight.

1. Pick a consistent wake time and protect it across weekends. Regularity beats duration; regularity beats almost every sleep supplement.
2. Move caffeine earlier than instinct. Its half-life is long enough that a 2 PM coffee is still present in meaningful concentration at bedtime for slow metabolizers.
3. Alcohol produces sedation that looks like sleep but eats REM. The next-morning grogginess is the cost, and the feedback loop of poor sleep plus next-day alcohol is how multi-year sleep debt builds.
4. Engineer the bedroom: cool room (mid-60s°F), dark, quiet, minimal screens in the last hour. A mattress-cooling system earns its slot for hot sleepers because temperature is the ignition signal for sleep onset.
5. Avoid using the bed as a battleground. If sleep does not come in 20 minutes, leave the room, do something low-stimulation, return when sleepy.
6. Exercise improves sleep, but late-evening intensity can push sleep onset. If evening workouts hurt sleep, move them earlier or lower intensity on evening days.

Kevin Rose Show — Matt Walker, Sleep 2.0 (Aug 15, 2024) — Episode #66

Show Notes

Three years later Walker returns with a gadget-aware update. Rose is now funding an antioxidant-based sleep study through his newsletter subscribers, and the conversation shifts toward the next wave of sleep-enhancement tools — stimulation devices, temperature control, and the honest limits of consumer sleep trackers.

1. Consumer sleep trackers (Oura, WHOOP, Apple Watch) are directionally correct for trend tracking and unreliable for single-night precision. Use them for weekly averages, not nightly verdicts.
2. Avoid reading your tracker first thing in the morning. "Orthosomnia" — anxiety about the score — is a growing problem and can itself make sleep worse.
3. The Somnee class of stimulation headbands is the most interesting consumer-facing sleep-enhancement tool with real published data. Budget for the novelty effect; retest after 30 days.
4. Supplements for sleep cluster into a short real list (magnesium, apigenin, theanine, glycine) and a long placebo-flavored list. The difference is that the real ones have plausible mechanism and consistent small effect sizes.
5. Temperature is the most reliable non-drug sleep lever. A cooling mattress or pre-bed cool shower produces a measurable improvement in sleep onset and depth.
6. Treat caffeine, alcohol, THC, and late exercise as a four-variable system. Adjust one at a time over two-week windows to see which actually drives your tracker numbers.

Fasting, ketones, and metabolic control

Fasting shows up across more than a decade of Rose's episodes. The long arc is that aggressive daily fasting gives way to more conservative windows, structured FMD cycles, and targeted tools like exogenous ketones and GLP-1 agonists. The hormetic stress protocols post is the companion on dosing these inputs correctly.

The Random Show — Fasting, Biohacking, and Tony Robbins (Aug 17, 2018) — Episode #333

Transcript

The Random Show that introduced FMD to a wide audience. Rose and Ferriss walk through the five-day fast mechanics, Attia's keto-adjusted version, N-acetylcysteine for hangover defense, L-theanine for alcohol modulation, and lithium orotate at low dose. A lot of these ideas became mainstream biohacking shortly after.

1. Approach the FMD as a planned protocol, not an impulse. Block the calendar, reduce training volume, and eat the prescribed ramp meal before and after.
2. Treat N-acetylcysteine narrowly: it supports glutathione and may blunt some alcohol effects, but it is not a license to drink more and is not a daily supplement for most stacks.
3. L-theanine at 200mg paired with caffeine smooths stimulation without blunting the focus benefit. It is also a reasonable as-needed anti-jitter supplement.
4. Low-dose lithium orotate is a long-running Rose experiment; it is a pharmaceutical at higher doses and should be run with full disclosure to a clinician, not from a supplement-store shelf.
5. Protein stays high during eating windows, even within tighter intermittent fasting. Losing muscle in the name of fasting is a fast path to worse outcomes.
6. Minimalism ports to stack design. The fewer compounds you run, the faster you can attribute effects; cut anything you cannot justify with a stop rule and a measurable outcome.

The Random Show — Biohacking, Saffron, and Ozempic (Nov 23, 2021) — Episode #549

Transcript

This is the episode where Rose publicly logged his early Ozempic experiment, added saffron as a mood compound, and admitted that poor glucose tolerance was driving the decision. In hindsight it was the leading-indicator episode for how GLP-1s would reshape biohacker protocols over the next three years.

1. GLP-1 agonists work partly because they change food-reward signaling, not just satiety. That same mechanism is why nausea and food aversion are the most common side effects early in the protocol.
2. Track lean mass during any GLP-1 trial. Monthly DEXA or a consistent bioimpedance routine is cheaper than finding out six months in that you lost 15% of your muscle.
3. Saffron at clinically studied doses (roughly 28–30 mg/day of a standardized extract) has meta-analytic support for mild-to-moderate depressive symptoms. Treat it like the mild antidepressant it behaves as, including for drug interaction checks.
4. Apigenin (from Kevin's PYM mood-chew stack mentions) is one of the shorter list of plausibly useful mood-and-sleep compounds. It is also an aromatase inhibitor at higher doses; respect the ceiling.
5. Glucose tolerance testing is useful once in a while. A single OGTT plus a two-week CGM wear is usually enough to inform dietary decisions for years.
6. For home medical experiments, clinician involvement is the difference between a bounded experiment and a lawsuit. Telehealth has made this easier, not optional.

Kevin Rose Show — Beyond Ozempic, Pendulum Akkermansia (Oct 28, 2024) — Episode #72

Show Notes

Three years later Rose comes back to the same problem — glucose variance and compulsive eating — with a different tool. This episode is the case for using a GLP-1-adjacent probiotic (Akkermansia muciniphila) rather than a pharmaceutical for people who want the glucose-stability effect without the prescription path.

1. Akkermansia muciniphila is the best-studied "GLP-1-adjacent" probiotic. Early human data suggests meaningful glucose and insulin improvements; effect size is smaller than pharmaceuticals.
2. Use it as a glucose-stability tool, not a weight-loss drug replacement. Expect modest appetite reduction, not the 10-15% body-weight reductions GLP-1 agonists produce.
3. Continue bloodwork regardless of route. HbA1c, fasting insulin, and ApoB still drive the decision; the bloodwork interpretation guide explains how to sequence them.
4. Probiotic quality is a supply-chain problem. Dead cells on the shelf are the most common failure mode; cold-chain products from companies that publish CFU counts at end-of-life are the minimum bar.
5. If you run a probiotic experiment, run it alone. Changing diet, adding fiber, and starting a new probiotic at once hides which one actually did the work.
6. Stack probiotics with fermented foods and diverse plant fibers; the substrate matters. A probiotic dropped into a low-fiber standard American diet usually does nothing.

Brain stimulation and mental-health frontiers

The Random Show has been one of the earliest podcasts to cover accelerated TMS, ketamine therapy, and ketone-based cognitive interventions for public audiences. The common structure is the same as the rest of the show's output: clinician-supervised, bounded, logged.

The Random Show — Accelerated TMS and SAINT Protocol (Sep 1, 2023) — Episode #690

Transcript

Ferriss walks through accelerated TMS (the SAINT/SNT protocol out of Stanford's Nolan Williams lab) as a treatment for OCD and generalized anxiety. Rose is the calibrating voice: he keeps asking for data, costs, and who is actually delivering the protocol. The conversation is the template for how to evaluate a novel neuromodulation tool.

1. Accelerated TMS (roughly 50 sessions over 5 days, 10 sessions per day, targeted via fMRI) is a legitimate medical intervention with large effect sizes in treatment-resistant depression. It is not a lifestyle biohack.
2. The clinic and the operator matter as much as the hardware. Targeting precision drives outcomes; poorly targeted TMS is how people spend $20k for a null result.
3. Before paying for the full protocol, get a second opinion from a clinician who is not selling the procedure. The selection bias at SAINT-branded clinics is real.
4. Pair any neuromodulation trial with a standardized pre/post assessment. PHQ-9, Y-BOCS, or equivalent are the instruments that tell you whether the effect persisted past the placebo window.
5. For lower-cost vagus-nerve stimulation experiments, the consumer devices produce small, noisy effects. Breathwork (physiological sighs, 4-7-8) produces most of the signal at zero cost.
6. Keep supplements and psychiatric medications stable during the trial. Changing stimulants, SSRIs, or sleep aids in the middle of a TMS protocol makes the signal uninterpretable.

Kevin's working supplement stack

Unlike most biohacking hosts, Rose publishes his stack and updates it. The public version — posted on his newsletter and refreshed on schedule — is the closest thing to a "what does a serious self-experimenter actually run daily" snapshot on the internet. It is also short, which is part of the point. For a broader view of how to compose a stack around goals, read the complete guide to supplement stacks.

Kevin Rose — My Supplement Stack (updated ongoing)

Public Stack Post

The stack is a short list built around labs, a longevity tilt, and a strong preference for third-party-tested brands. The editorial call-outs below are paraphrased from Rose's own write-up; doses are public and reflect his routine, not a prescription.

1. Vitamin D3, with dose windows calibrated to labs — Rose targets roughly 50 ng/mL serum via supplementation, because his baseline without it runs low. The product (VESIsorb-formulated) is chosen for bioavailability, not brand loyalty.
2. A whole-food multivitamin as gap insurance. This is the one spot in the stack where "just in case" earns its place, because the downside of a micronutrient hole on a clean-ish diet is small and slow to detect.
3. Ubiquinol at roughly 100 mg daily for cardiovascular support. CoQ10 status is worth checking in anyone on statins or with a family cardiac history.
4. Omega-3 at ~2 grams of EPA + DHA per day, in triglyceride form, from a tested brand. The correct dose is the one that pushes the Omega-3 Index into range; anchor it to a blood test, not a bottle.
5. Creatine at 5 g on training days, lower on off days. Rose uses the HCl form for gut tolerance; the monohydrate evidence base is still stronger and either works. This is the single supplement with the best cost-to-benefit ratio in the whole stack.
6. The longevity micro-stack of taurine (~1 g), PQQ (~20 mg), and ergothioneine (~5 mg). These are the experimental tier: plausible mechanism, early human data, and no expected downside at these doses. Expect to cycle or retire them if better evidence moves the picture.
7. Zinc lozenges as an acute-use tool at the first sign of an upper respiratory infection or before flights. This is a narrow, time-limited dose, not a daily background supplement.
8. Protein in food-first form (ProMix or similar), sized to hit 1.6–2.2 g/kg across the week. The supplement stack is designed to ride on top of adequate protein, not to replace it.

The stack is also a study in negative space. What is not on it — NMN, resveratrol, NR, high-dose B-complex, random adaptogen blends, SARMs, proprietary nootropic stacks — is arguably the more interesting column. Rose has run several of these and dropped them because the return on effort did not clear the bar. The pattern for readers is straightforward: keep the short list tight, label everything with a clear evidence tier, and audit the stack twice a year against updated labs.

How Unfair uses this

Rose's durable contribution is the operating system behind all the gadget coverage: buy the tool, run the experiment, hold the labs against the compound, decide keep/adjust/drop on data. That is the mental model Unfair is built around.

If you want to apply the patterns from this rollup to your own stack, three moves do most of the work:

1. Shrink the stack to its defensible core. Rose's own published list is eight things for a reason. Audit what you are currently taking and drop anything that cannot justify its existence with a labs-backed outcome. The supplement stack mistakes post is the checklist; Unfair surfaces overlap, duplicate ingredients, and interaction checks automatically the moment you import a stack.
2. Treat [timing](/blog/understanding-dose-windows-and-cycles) as a first-class feature. Morning creatine, evening magnesium, zinc only during an acute illness, FMD cycles quarterly — every item above is as much a schedule as a compound. Unfair's cycle-aware reminders keep these moving without a second app.
3. Run a clean log behind every new gadget or compound. Methylene blue, urolithin A, a sleep headband, a photobiomodulation laser — each earns or loses its slot based on a one-metric decision. Unfair's stack journal and streaks turn the "keep / adjust / drop" decision into a data decision, not a vibes one.

For the companion show-level views across the biohacker-podcast space, see the Tim Ferriss rollup and the Huberman Lab rollup. For the biomarker side that sits under most of Rose's decisions, the bloodwork interpretation guide is the right next read.

If there is a Random Show or Kevin Rose Show episode that belongs here and is missing, tell us.